Three Republican-led states have moved to broaden their lawsuit seeking to restrict access to the abortion pill mifepristone, ...
Medication abortions account for more than 60 percent of all abortions in the United States, up from just a quarter a decade ...
Missouri, Idaho, and Kansas updated their complaint in an ongoing legal battle against the FDA’s loosened restrictions that ...
The FDA approved a new generic form of mifepristone in September, expanding the accessibility of a common abortion medication ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results